GregoryA.FlemingMDMSc, FSCAI, FPICS
Pediatric Cardiology • Durham, NCPediatric Interventional Cardiology
Professor of Pediatrics, Duke University School of Medicine Medical Director, Pediatric and Congenital Cath Labs
Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7506 Duke Hospital North
DUMC BOX 3090
Durham, NC 27710Phone+1 919-681-6772Fax+1 919-681-8927
Summary
- Dr. Gregory Fleming is a pediatric cardiologist in Durham, NC and is affiliated with multiple hospitals in the area, including Duke University Hospital and Moses H. Cone Memorial Hospital. He received his medical degree from University of South Carolina School of Medicine, and post graduate training at Vanderbilt University. He has been in practice 10 years. He specializes in pediatric interventional cardiology and is also board certified in adult congenital heart disease. He serves as Medical Director of the Pediatric and Congenital Cardiac Catheterization Lab at Duke. He is also medical director of the Fontan Multispecialty Clinic at Duke.
Education & Training
Vanderbilt University Medical CenterFellowship, Pediatric Cardiology, 2006 - 2010- Vanderbilt University Medical CenterResidency, Pediatrics, 2003 - 2006
University of South Carolina School of MedicineClass of 2003
Certifications & Licensure
NC State Medical License 2010 - 2025
TN State Medical License 2009 - 2010- American Board of Pediatrics Pediatric Cardiology
- American Board of Internal Medicine Adult Congenital Heart Disease
Clinical Trials
- Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study Start of enrollment: 2008 Mar 01
- COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV Start of enrollment: 2008 Apr 08
- Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 63 citationsCRISP: Catheterization RISk score for pediatrics: A Report from the Congenital Cardiac Interventional Study Consortium (CCISC)David G. Nykanen, Thomas J. Forbes, Wei Du, Abhay Divekar, Jaxk Reeves
Catheterization and Cardiovascular Interventions. 2016-02-01 - 11 citationsPost-market surveillance to detect adverse events associated with Melody® valve implantation.Kevin D. Hill, Bryan H. Goldstein, Michael J. Angtuaco, Patricia Y. Chu, Gregory A. Fleming
Cardiology in the Young. 2017-08-01 - 2 citationsEstimating radiation exposure during paediatric cardiac catheterisation: a potential for radiation reduction with air gap techniqueReid C. Chamberlain, Alexis C. Shindhelm, Chu Wang, Gregory A. Fleming, Kevin D. Hill
Cardiology in the Young. 2019-11-04
Journal Articles
- Structural 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position from the COMPASSION Multicenter Clinical TrialGregory A Fleming, Girish S Shirali, Mark A Fogel, Julie Vincent, Vasilis C Babaliaros, Dennis W Kim, Evan M Zahn, John F Rhodes, Saibal Kar, Aimee K Armstrong, ScienceDirect
- Validation and Refinement of the Catheterization RISk Score for Pediatrics (CRISP Score): An Analysis from the Congenital Cardiac Interventional Study ConsortiumGregory A Fleming, David G Nykanen, Thomas J Forbes, Kevin D Hill, Daisuke Kobayashi, Catheterization and Cardiovascular Interventions
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
